<img src="//d5nxst8fruw4z.cloudfront.net/atrk.gif?account=o2fZk1a4eFf2uW" style="display:none" height="1" width="1" alt="" /> Contestedstreets.com
Close Menu

Executives from 23andMe, Myriad Genetics, Genomic Health, and Alere provided updates on their companies at the JP Morgan Healthcare Conference in San Francisco.

Illumina's Grail will begin large-scale clinical trials in 2017 and aims to launch a blood-based NGS pan-cancer screening test for $1,000 or less in 2019.

The price of $14 per share represents a 52 percent premium to Affymetrix's closing price of $9.21 on Friday. 

The technique, which runs on Bruker Fourier transform ion cyclotron resonance mass spectrometers, can provide 1,000-fold greater detail on protein structure.

Illumina Unveils Mini Targeted - | - | = Sequencer, Semiconductor Sequencing Project at JP Morgan Conference

The company also announced the Infinium XT genotyping array for analyzing large sample numbers, and provided preliminary earnings for Q4 and full-year 2015.

The firms will develop a cost-effective, scalable solution that incorporates Bio-Rad's droplet partitioning technology with Illumina's NGS and BaseSpace data analysis.

The US National Institutes of Health seeks to avoid the errors of the National Children's Study with its Precision Medicine Initiative.

In PLOS this week: sequencing of fecal samples gives clues to killer whales' diet, sporulation genes in Bacillus subtilis, and more.

Researchers update the estimation of how many bacterial cells are found in and on the human body.

In Science this week: sequencing finds Helicobacter pylori in a 5,300-year-old European glacial mummy, and more.

Sponsored by
National Center for Biotechnology Information

This webinar highlights important features and demonstrates the practical aspects of using the NCBI BLAST service.

Quantitative real-time PCR (qPCR) is maturing as a technology, diagnostics performed today. Behind this success is the field’s increasing awareness becom­ing the central platform and gold standard for much of the molecular research and molecular of the importance of quality control, validation, and performance assessment.

Lucigen has developed an NGS library technology that generates 20 kb mate pair reads that jump across repetitive elements found in microbial genomes (www.lucigen.com/matepair), which dramatically improves the success of assembly de novo by resolving repeat elements and ordering contigs. Six microbial genomes have been assembled de novo and completely closed and finished using Lucigen’s NxSeq® 20 kb mate pair library kit, a companion fragment library, and SPAdes assembly software.